Open AccessInvasive Fungal Infection in COVID-19–Recovered Patient Detected on 18F-FDG–Labeled Leukocytes PET/CT Scan
Author(s) -
Divya Manda,
Ishita Sen,
Parul Thakral,
Subha Shankar Das,
Virupakshappa Cb,
Dharmender Malik
Publication year - 2021
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000003852
Subject(s) - medicine , mucormycosis , covid-19 , lung , intensive care unit , pathology , radiology , infectious disease (medical specialty) , disease
Occurrence of invasive fungal infections has gained significant attention during recent times in patients with COVID-19. Patients with severe form of COVID-19, such as those treated in the intensive care unit with prolonged steroid use, are particularly vulnerable to secondary bacterial and fungal infections. Disseminated systemic mycosis is a life-threatening condition, especially in immunocompromised patients. Here, we report a case of a recovered severe COVID-19 patient, who presented with persistent fever. 18F-FDG-labeled leukocyte scan revealed focal accumulation of radiotracer in the small intestine and right lung lower lobe. Subsequently, performed biopsy revealed mucormycosis.